IDPC

Past Events

Results 805 to 816 of 1504
Canada's Drug Futures Forum

Canada's Drug Futures Forum

Ottawa, Canada
3 April 2017 - 4 April 2017
Recent decisions by the Canadian government concerning harm reduction, opioids, cannabis, and sentencing are signalling a new approach to managing illicit drug use in Canada.
Regional CEECA Harm Reduction Conference 2017

Regional CEECA Harm Reduction Conference 2017

Vilnius, Lithuania
3 April 2017 - 5 April 2017
The Regional Harm Reduction Conference will be dedicated to the results, lessons learnt, and perspectives of civil society and community-driven advocacy for sustainable and high-quality harm reduction programs in CEECA.
Drug Policy in Austria

Drug Policy in Austria

Vienna, Austria
16 March 2017
The first 2017 Human Rights Talk discusses "Two steps forward and one step back on the road to human rights based drug policy in Austria".
Scottish National User Involvement conference

Scottish National User Involvement conference

Edinburgh, Scotland
1 March 2017
Topics include: Raising awareness & promoting the role of user involvement, considering examples of good practice in user involvement, and identifying and tackling barriers to user involvement.
LEAP +1: Drug policy one year on

LEAP +1: Drug policy one year on

London, UK
28 February 2017
LEAP UK ask how has drug policy evolved since last year, what can the UK expect, and where does it go from here?
Harm Reduction Academy Cycle 3

Harm Reduction Academy Cycle 3

26 February 2017 - 15 June 2017
Harm Reduction Academy is a global learning, dialogue and skills building course established with the vision to end AIDS and Hepatitis C among people who inject drugs.
CND Intersessional Meeting

CND Intersessional Meeting

Vienna, Austria
23 February 2017
The second CND intersessional meeting 2017 will discuss preparations for the 60th session of the CND.
Drug policies beyond the War on Drugs?

Drug policies beyond the War on Drugs?

London, England
14 February 2017
The London School of Economics asks how research can impact government policy as countries examine new ways of managing drug issues beyond the problematic and simplistic model of the 'war on drugs'.